|
|
|
|
The week in vaccines: check out the most recent posts
|
|
|
|
|
|
|
|
|
In October 2024 WHO certified Egypt as malaria-free after a “nearly 100-year effort” by the government and people to end the disease. WHO described
|
|
|
|
|
|
|
|
|
|
|
Research in Nature in October 2024 leverages evidence that bacteria “naturally home in on tumours and modulate antitumour immunity” to explore
|
|
|
|
|
|
|
|
|
|
|
The Global Polio Eradication Initiative (GPEI) announced the “difficult decision” to extend the timelines needed to achieve polio eradication.
|
|
|
|
|
|
|
|
|
|
|
In October 2024 the Animal and Plant Health Agency (APHA) and The Vaccine Group (TVG) announced that Innovate UK has awarded them a Smart
|
|
|
|
|
|
|
|
|
|
|
Valneva and LimmaTech Biologics announced in October 2024 that they have been granted Fast Track designation by the United States FDA for Shigella4V
|
|
|
|
|
|
|
Top post from last week:
| The most viewed post from last week explores a paper on the NeoDisc pipeline and its uses in personalised cancer immunotherapy. |
|
|
|
|
|
|
|
A paper in Nature Biotechnology in October 2024 presents an “end-to-end clinical proteogenomic pipeline” to address the challenges associated
|
|
|
|
|
|
|
 |
Contribute to VaccineNation:
| If you'd like to see your news or opinion featured in this newsletter and on the site, get in touch via email: This email address is being protected from spambots. You need JavaScript enabled to view it. with details of your contribution. We look forward to hearing from you! |
|
|
|
|
|
|
This email was sent by a company owned by Terrapinn Holdings, registered office at
Wren House, 43 Hatton Garden, London, EC1N 8EL, United Kingdom
|
|
| |
|
